CatScI Ltd.

CatScI Ltd.


Company description

CatSci Ltd was established in December 2010, spun out of the erstwhile Catalyst Screening Facility at AstraZeneca's Avlon Works.  Now with a staff of 35 and growing, the company is managed by a team with decades of experience in pharmaceuticals. CatSci Ltd is a scientifically unbiased process research and development CRO that provides tailored chemistry services to emerging, mid-sized and large pharma companies across the globe.  We aspire to develop economically and environmentally sustainable chemical processes so that our customers can deliver affordable best-in-class small molecule therapeutics to meet the evolving healthcare needs of the world. 

Our services include route design, process development, scale-up and optimisation, and non-GMP material supply in order to support CMC demands from IND enabling and candidate selection through clinical development to product launch and life-cycle management.  As an independent and commercially minded CRO, we are a reliable and trusted partner for innovation.  

Recent recognition includes wins at the CPhI Pharma Awards 2018 (Excellence in Pharma: Contract Services and Outsourcing) and at the Cardiff Business Awards 2019 (International Business of the Year).  We are fiercely dedicated to working together with all our stakeholders to build the leading independent pharmaceutical process research and development CRO. 

Quick facts

Sales markets Western Europe; North America
Affiliated categories: Process Optimisation |Synthetic Organic Chemistry |Synthetic Route Design More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41H20 See our Exhibitor Profile   See full Exhibitor List

News about CatScI Ltd.

CatSci continues global expansion into North America and beyond

14 Oct 2019

CatSci continues global expansion into North America and beyond

CatSci, a fast growing, adaptable and award-winning process research and development contract research organisation (CRO), is furthering its global growth strategy to support innovator pharma in meeting their Chemistry, Manufacturing and Controls (CMC) demands.

Read more
CatScI Ltd.

Contact information




View all contact information